Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Correction of Myopia Evaluation Trial 2

NCT: NCT00320593 · COMPLETED

NCT IDNCT00320593
StatusCOMPLETED
Start Date2005-04
Completion2010-03
SponsorJaeb Center for Health Research (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.

Frequently Asked Questions

What is Correction of Myopia Evaluation Trial 2?

Correction of Myopia Evaluation Trial 2 is a clinical trial registered under NCT00320593. Current status: COMPLETED.

What is the status of NCT00320593?

The current status of NCT00320593 (Correction of Myopia Evaluation Trial 2) is: COMPLETED.

When did Correction of Myopia Evaluation Trial 2 start?

Correction of Myopia Evaluation Trial 2 started on 2005-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.